143 related articles for article (PubMed ID: 26509248)
21. Comparison of clinicopathologic features, survival, and demographics in sebaceous carcinoma patients with and without Muir-Torre syndrome.
Maloney NJ; Zacher NC; Hirotsu KE; Rajan N; Aasi SZ; Kibbi N
J Am Acad Dermatol; 2023 Aug; 89(2):269-273. PubMed ID: 37003478
[TBL] [Abstract][Full Text] [Related]
22. [Muir-Torre syndrome associated with Waldenstrom's macroglobulinemia].
Velter C; Bourlond F; Wettle C; Lioure B; Lipsker D; Maugard C; Cribier B
Ann Dermatol Venereol; 2016 Dec; 143(12):825-830. PubMed ID: 27771121
[TBL] [Abstract][Full Text] [Related]
23. [Muir-Torre syndrome: rare association with duodenal carcinoma].
Bacha D; Deschamps L; Sauvanet A; Couvelard A
Ann Pathol; 2009 Dec; 29(6):495-8. PubMed ID: 20005439
[TBL] [Abstract][Full Text] [Related]
24. Muir-Torre syndrome: a rare but important disorder.
Hare HH; Mahendraker N; Sarwate S; Tangella K
Cutis; 2008 Oct; 82(4):252-6. PubMed ID: 19055168
[TBL] [Abstract][Full Text] [Related]
25. Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018.
Cook S; Pethick J; Kibbi N; Hollestein L; Lavelle K; de Vere Hunt I; Turnbull C; Rous B; Husain A; Burn J; Lüchtenborg M; Santaniello F; McRonald F; Hardy S; Linos E; Venables Z; Rajan N
J Am Acad Dermatol; 2023 Dec; 89(6):1129-1135. PubMed ID: 37031776
[TBL] [Abstract][Full Text] [Related]
26. Somatic MMR gene mutations as a cause for MSI-H sebaceous neoplasms in Muir-Torre syndrome-like patients.
Joly MO; Attignon V; Saurin JC; Desseigne F; Leroux D; Martin-Denavit T; Giraud S; Bonnet-Dupeyron MN; Faivre L; Auclair J; Grand-Masson C; Audoynaud C; Wang Q
Hum Mutat; 2015 Mar; 36(3):292-5. PubMed ID: 25504677
[TBL] [Abstract][Full Text] [Related]
27. Papillary Renal Cell Carcinoma in Lynch/Muir-Torre Syndrome with Germline Pathogenic Variant in
Yang Y; Dhar S; Taylor J; Krishnan B
J Kidney Cancer VHL; 2021; 8(2):8-19. PubMed ID: 33977078
[TBL] [Abstract][Full Text] [Related]
28. Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome).
Hubosky SG; Boman BM; Charles S; Bibbo M; Bagley DH
BJU Int; 2013 Oct; 112(6):813-9. PubMed ID: 23452166
[TBL] [Abstract][Full Text] [Related]
29. Myxofibrosarcoma harboring an MLH1 pathogenic germline variant associated with Muir-Torre syndrome: a case report.
Nakagawa M; Kobayashi E; Yamada M; Watanabe T; Hirata M; Tanabe N; Ushiama M; Sakamoto H; Sato C; Mori T; Yoshida A; Yoshida T; Sugano K; Kawai A
Hered Cancer Clin Pract; 2021 Aug; 19(1):34. PubMed ID: 34419117
[TBL] [Abstract][Full Text] [Related]
30. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous Sebaceous Lesions in a Patient With MUTYH-Associated Polyposis Mimicking Muir-Torre Syndrome.
Kacerovska D; Drlik L; Slezakova L; Michal M; Stehlik J; Sedivcova M; Hadravsky L; Kazakov DV
Am J Dermatopathol; 2016 Dec; 38(12):915-923. PubMed ID: 27870730
[TBL] [Abstract][Full Text] [Related]
32. Retroperitoneal undifferentiated pleomorphic sarcoma having microsatellite instability associated with Muir-Torre syndrome: case report and review of literature.
Lee N; Luthra R; Lopez-Terrada D; Wang WL; Lazar AJ
J Cutan Pathol; 2013 Aug; 40(8):730-3. PubMed ID: 23672746
[TBL] [Abstract][Full Text] [Related]
33. A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome.
Perera S; Ramyar L; Mitri A; Pollett A; Gallinger S; Speevak MD; Aronson M; Bapat B
J Hum Genet; 2010 Jan; 55(1):37-41. PubMed ID: 19911012
[TBL] [Abstract][Full Text] [Related]
34. Metachronous occurrence of colorectal cancer in a muir-torre syndrome patient presenting with recurrent sebaceous adenoma of the eyelid: case report and updated review of the literature.
Agiannidis C; Pana ZD; Molyva D; Kalokasidis K; Mixiou M
J Cutan Med Surg; 2012; 16(6):394-9. PubMed ID: 23149194
[TBL] [Abstract][Full Text] [Related]
35. A case report of Muir-Torre syndrome in a woman with breast cancer and MSI-Low skin squamous cell carcinoma.
Kientz C; Joly MO; Faivre L; Clemenson A; Dalac S; Lepage C; Chapusot C; Jacquot C; Schiappa R; Lebrun M
Hered Cancer Clin Pract; 2017; 15():6. PubMed ID: 28507641
[TBL] [Abstract][Full Text] [Related]
36. Family with MSH2 mutation presenting with keratoacanthoma and precancerous skin lesions.
Hatta N; Takata A; Ishizawa S; Niida Y
J Dermatol; 2015 Nov; 42(11):1087-90. PubMed ID: 26077460
[TBL] [Abstract][Full Text] [Related]
37. [The tip of the iceberg: multiple cutaneous sebaceous tumor in colon cancer. Muir-Torre syndrome--case report].
Herr G; Szenes M; Hohl G; Vinkler ME; Tüske G; Horváth J; Nagy G; Tihanyi M; Széll M; Nagy N; Gasztonyi B
Orv Hetil; 2015 Jun; 156(24):979-84. PubMed ID: 26051134
[TBL] [Abstract][Full Text] [Related]
38. Reticulated acanthoma with sebaceous differentiation: another sebaceous neoplasm associated with Muir-Torre syndrome?
Shon W; Wolz MM; Newman CC; Bridges AG
Australas J Dermatol; 2014 Nov; 55(4):e71-3. PubMed ID: 23651324
[TBL] [Abstract][Full Text] [Related]
39. A squamous cell carcinoma in a young woman with Lynch syndrome.
Adan F; Crijns MB; Dekker E; Bastiaansen BAJ; Lapid O; Snaebjornsson P; Rosenberg EH; van Leerdam ME; Bekkenk MW
Fam Cancer; 2019 Apr; 18(2):193-196. PubMed ID: 30560308
[TBL] [Abstract][Full Text] [Related]
40. Muir-Torre Syndrome and Central Nervous System Malignancy: Highlighting an Uncommon Association.
Kurtzman DJ; Fabiano AJ; Qiu J; Zeitouni NC
Dermatol Surg; 2015 Jul; 41(7):856-9. PubMed ID: 26035046
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
